title: 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies).
abstract: The 2016 10th Workshop on Recent Issues in Bioanalysis (10thWRIB) took place in Orlando, Florida with participation of close to 700 professionals from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract research organizations, and regulatory agencies worldwide. WRIB was once again a 5-day, weeklong event - A Full Immersion Week of Bioanalysis including Biomarkers and Immunogenicity. As usual, it is specifically designed to facilitate sharing, reviewing, discussing and agreeing on approaches to address the most current issues of interest including both small and large molecules involving LCMS, hybrid LBA/LCMS, and LBA approaches, with the focus on biomarkers and immunogenicity. This 2016 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop, and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. This White Paper is published in 3 parts due to length. This part (Part 2) discusses the recommendations for Hybrid LBA/LCMS and regulatory inputs from major global health authorities. Parts 1 (small molecule bioanalysis using LCMS) and Part 3 (large molecule bioanalysis using LBA, biomarkers and immunogenicity) have been published in the Bioanalysis journal, issues 22 and 23, respectively.
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: An
authors.initials: A
authors.lastname: Song
authors.affiliation: Merck & Co., Inc., Rahway, NJ, USA.
authors.forename: Anita
authors.initials: A
authors.lastname: Lee
authors.affiliation: Angelini Pharma, Pomezia, RM, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Garofolo
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Surinder
authors.initials: S
authors.lastname: Kaur
authors.affiliation: Boehringer-Ingelheim, Ridgefield, CT, USA.
authors.forename: Jeff
authors.initials: J
authors.lastname: Duggan
authors.affiliation: GlaxoSmithKline, King of Prussia, PA, USA.
authors.forename: Christopher
authors.initials: C
authors.lastname: Evans
authors.affiliation: Pfizer, Andover, MA, USA.
authors.forename: Joe
authors.initials: J
authors.lastname: Palandra
authors.affiliation: Caprion Biosciences, Montreal, QC, Canada.
authors.forename: Lorella Di
authors.initials: LD
authors.lastname: Donato
authors.affiliation: Genentech, South San Francisco, CA, USA.
authors.forename: Keyang
authors.initials: K
authors.lastname: Xu
authors.affiliation: Austria AGES, Wien, Austria.
authors.forename: Ronald
authors.initials: R
authors.lastname: Bauer
authors.affiliation: Health Canada, Ottawa, ON, Canada.
authors.forename: Mark
authors.initials: M
authors.lastname: Bustard
authors.affiliation: Boehringer-Ingelheim, Ridgefield, CT, USA.
authors.forename: Linzhi
authors.initials: L
authors.lastname: Chen
authors.affiliation: Health Canada, Ottawa, ON, Canada.
authors.forename: Laurent
authors.initials: L
authors.lastname: Cocea
authors.affiliation: WHO, Geneva, Switzerland.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Croft
authors.affiliation: Italy AIFA, Rome, Italy.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Galliccia
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Sam
authors.initials: S
authors.lastname: Haidar
authors.affiliation: Bioanalytical Laboratory Services a Division of LifeLabs LP, Toronto, ON, Canada.
authors.forename: Nicola
authors.initials: N
authors.lastname: Hughes
authors.affiliation: Japan MHLW-NIHS, Tokyo, Japan.
authors.forename: Akiko
authors.initials: A
authors.lastname: Ishii-Watabe
authors.affiliation: Celerion, Lincoln, NE, USA.
authors.forename: Rafiqul
authors.initials: R
authors.lastname: Islam
authors.affiliation: Q2 Solutions, Ithaca, NY, USA.
authors.forename: Barry
authors.initials: B
authors.lastname: Jones
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: John
authors.initials: J
authors.lastname: Kadavil
authors.affiliation: Novartis, Basel, Switzerland.
authors.forename: Carsten
authors.initials: C
authors.lastname: Krantz
authors.affiliation: Brazil ANVISA, Brasilia, Brazil.
authors.forename: Gustavo Mendes
authors.initials: GM
authors.lastname: Lima Santos
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Timothy
authors.initials: T
authors.lastname: Olah
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: João
authors.initials: J
authors.lastname: Pedras-Vasconcelos
authors.affiliation: UCB Biopharma, Braine L'Alleud, Belgium.
authors.forename: Ludovicus
authors.initials: L
authors.lastname: Staelens
authors.affiliation: Japan MHLW-NIHS, Tokyo, Japan.
authors.forename: Yoshiro
authors.initials: Y
authors.lastname: Saito
authors.affiliation: CFABS, Montreal, QC, Canada.
authors.forename: Natasha
authors.initials: N
authors.lastname: Savoie
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Kara
authors.initials: K
authors.lastname: Scheibner
authors.affiliation: Formerly MedImmune, Gaithersburg, MD, USA; currently Incyte Corporation, Wilmington, DE, USA.
authors.forename: Susan
authors.initials: S
authors.lastname: Spitz
authors.affiliation: US FDA, Silver Spring, MD, USA.
authors.forename: Nilufer
authors.initials: N
authors.lastname: Tampal
authors.affiliation: Covance, Indianapolis, IN, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Thomas
authors.affiliation: UK MHRA, London, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Vinter
authors.affiliation: UK MHRA, London, UK.
authors.forename: Jason
authors.initials: J
authors.lastname: Wakelin-Smith
authors.affiliation: Dutch MEB, Utrecht, The Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: Welink
authors.affiliation: Bristol-Myers Squibb, Princeton, NJ, USA.
authors.forename: Jianing
authors.initials: J
authors.lastname: Zeng
authors.affiliation: Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland.
authors.forename: Shaolian
authors.initials: S
authors.lastname: Zhou
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000032:analysis / Q000276:immunology; D015415:Biomarkers / Q000032:analysis*; D002851:Chromatography, High Pressure Liquid; D003245:Consensus Statements as Topic; D006077:Government Agencies; D006801:Humans; D007118:Immunoassay; D008024:Ligands; D013058:Mass Spectrometry; D054928:Validation Studies as Topic
chemical_list: D000888:Antibodies, Anti-Idiotypic; D015415:Biomarkers; D008024:Ligands